Literature DB >> 7639628

Alzheimer's disease in the National Academy of Sciences-National Research Council Registry of Aging Twin Veterans. III. Detection of cases, longitudinal results, and observations on twin concordance.

J C Breitner1, K A Welsh, B A Gau, W M McDonald, D C Steffens, A M Saunders, K M Magruder, M J Helms, B L Plassman, M F Folstein.   

Abstract

OBJECTIVES: To detect cases of Alzheimer's disease (AD) in a large population of twins living throughout the United States and to examine concordance for AD in twins as a function of age and genotype for apolipoprotein E (APOE).
SETTING: Nationwide survey.
DESIGN: Multistage screening and field evaluation beginning with two telephone interviews and culminating with laboratory tests, longitudinal neuropsychological measures, physician examination, and diagnostic consensus among experts. PARTICIPANTS: Membership in 1990-1991 of intact pairs in the National Academy of Sciences--National Research Council Registry of veteran twins, then aged 62 to 73 years. MAIN OUTCOME MEASURES: Completeness of case detection was examined in collateral studies. Zygosity and APOE genotypes were determined by restriction mapping. Concordance was calculated by the proband method.
RESULTS: Ninety subjects who screened positively for AD were studied in person, and 60 whose differential diagnoses included AD were followed up, as were their co-twins. Sensitivity of screening was estimated at greater than 99%, but 24% of subjects refused participation after initial screening. Seven of 38 diagnoses of AD have been confirmed at autopsy, and 31 other subjects eventually met criteria for probable or possible AD (prevalence estimate, 0.42%, 95% confidence interval, 0.29% to 0.56%), with good interrater reliability (intraclass r = .86). Excluding one discordant pair with unknown zygosity, concordance rates were 21.1% (4/19) for monozygotic and 11.1% (2/18) for dizygotic probands. Concordance was 50% for twins sharing the epsilon 4/epsilon 4 genotype at APOE, but there were no affected co-twins of 15 probands with onset before age 70 years, no epsilon 4 allele, and no family history of AD. The mean (SD) period of discordance in the latter pairs was 11.3 (3.3) years.
CONCLUSIONS: The multistage case-detection approach achieved reliable and valid diagnoses of AD with high apparent sensitivity but substantial attrition after initial screening. Genetic influences in AD at this age are limited, except among homozygotes for allele epsilon 4 at APOE. Subjects with early-onset AD who lack the epsilon 4 allele are not rare, and their condition appears to have little genetic influence. They should be ideal for studies on environmental cause of AD.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7639628     DOI: 10.1001/archneur.1995.00540320035011

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  35 in total

1.  Solvent exposures and Parkinson disease risk in twins.

Authors:  Samuel M Goldman; Patricia J Quinlan; G Webster Ross; Connie Marras; Cheryl Meng; Grace S Bhudhikanok; Kathleen Comyns; Monica Korell; Anabel R Chade; Meike Kasten; Benjamin Priestley; Kelvin L Chou; Hubert H Fernandez; Franca Cambi; J William Langston; Caroline M Tanner
Journal:  Ann Neurol       Date:  2011-11-14       Impact factor: 10.422

Review 2.  Biological basis of determinants of health.

Authors:  Walter M Bortz
Journal:  Am J Public Health       Date:  2005-03       Impact factor: 9.308

3.  Verification of self-report of zygosity determined via DNA testing in a subset of the NAS-NRC twin registry 40 years later.

Authors:  Terry Reed; Brenda L Plassman; Caroline M Tanner; Danielle M Dick; Shannon A Rinehart; William C Nichols
Journal:  Twin Res Hum Genet       Date:  2005-08       Impact factor: 1.587

4.  Prevalence and patterns of comorbid cognitive impairment in low vision rehabilitation for macular disease.

Authors:  Heather E Whitson; Deidra Ansah; Diane Whitaker; Guy Potter; Scott W Cousins; Heather MacDonald; Carl F Pieper; Lawrence Landerman; David C Steffens; Harvey J Cohen
Journal:  Arch Gerontol Geriatr       Date:  2009-05-07       Impact factor: 3.250

5.  Outcomes of older cognitively impaired individuals with current and past depression in the NCODE study.

Authors:  David C Steffens; Douglas R McQuoid; Guy G Potter
Journal:  J Geriatr Psychiatry Neurol       Date:  2009-02-04       Impact factor: 2.680

6.  Twin pairs discordant for neuropathologically confirmed Lewy body dementia.

Authors:  C Sheei-Meei Wang; J R Burke; D C Steffens; C M Hulette; J C S Breitner; B L Plassman
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-05       Impact factor: 10.154

7.  Effects of varying diagnostic criteria on prevalence of mild cognitive impairment in a community based sample.

Authors:  Emily H Trittschuh; Paul K Crane; Eric B Larson; Brenna Cholerton; Wayne C McCormick; Susan M McCurry; James D Bowen; Laura D Baker; Suzanne Craft
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

8.  Autosomal recessive causes likely in early-onset Alzheimer disease.

Authors:  Thomas S Wingo; James J Lah; Allan I Levey; David J Cutler
Journal:  Arch Neurol       Date:  2011-09-12

9.  Effects of family history and apolipoprotein E epsilon4 status on cognitive decline in the absence of Alzheimer dementia: the Cache County Study.

Authors:  Kathleen M Hayden; Peter P Zandi; Nancy A West; Joann T Tschanz; Maria C Norton; Chris Corcoran; John C S Breitner; Kathleen A Welsh-Bohmer
Journal:  Arch Neurol       Date:  2009-11

Review 10.  Genomic variants, genes, and pathways of Alzheimer's disease: An overview.

Authors:  Adam C Naj; Gerard D Schellenberg
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-01       Impact factor: 3.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.